how does a stock get delisted from nasdaq

Overview

how does a stock get delisted from nasdaq is a common question for investors and corporate managers. In plain terms, delisting on Nasdaq means a company’s equity is removed from the Nasdaq exchange — either voluntarily or involuntarily. This article explains the triggers for delisting, Nasdaq’s legal framework and timelines, the notices and cure periods provided, the hearing and appeals path, consequences for trading and stakeholders, and practical steps both issuers and investors can take. Readers will gain actionable guidance on prevention, remediation, and next steps after delisting.

As of 23 January 2026, according to Nasdaq’s Listing Rules and public guidance, the procedures and timelines described below reflect prevailing practice. Additional context and practical observations also draw on legal summaries and reputable finance sources available as of that date.

Background: Nasdaq’s role and continuing listing obligations

Nasdaq is a regulated securities exchange that lists thousands of U.S. and international companies. To maintain an orderly market and protect investors, Nasdaq requires listed companies to meet ongoing standards after their initial listing. These continuing listing obligations cover financial thresholds (market capitalization and shareholders’ equity), trading price standards (minimum bid price), public float and share distribution, corporate governance mandates (independent directors, audit committees), timely SEC reporting, and payment of exchange fees.

Those rules exist so that market participants can rely on a baseline of liquidity, transparency, and governance. When a company fails to meet one or more requirements, Nasdaq staff or automated surveillance may begin a delisting review. Understanding those ongoing obligations helps both issuers and investors anticipate and respond to potential delisting actions.

What is delisting?

Delisting means a security ceases to be listed on Nasdaq’s market. There are two broad types:

• Voluntary delisting: A company chooses to withdraw its shares from Nasdaq. Common reasons include going private transactions, mergers and acquisitions, strategic decisions to list elsewhere, or cost reduction. Voluntary delistings typically involve shareholder votes and negotiated transaction steps.
• Involuntary delisting: Nasdaq initiates removal because the issuer fails to comply with listing standards or violates rules — for example, persistent low trading price, market cap shortfalls, failure to file SEC reports, governance deficiencies, or evidence of fraud.

Both paths lead to removal from Nasdaq’s central order book; however, involuntary delisting generally involves a formal deficiency notice, cure periods, and an enforcement sequence that offers procedural protections to the issuer.

Common triggers and grounds for delisting

Companies can face delisting for many reasons. Common triggers include:

• Minimum bid price breaches: Nasdaq has a minimum closing bid price requirement (commonly $1.00) measured over a consecutive trading-day window. Failure to meet the minimum bid price is a frequent cause of deficiency notices.
• Insufficient market capitalization or public float: Listing standards require minimum market value or public float thresholds depending on the market tier (e.g., Nasdaq Global Select Market, Global Market, or Capital Market). Extended breaches may prompt delisting proceedings.
• Failure to file SEC reports: If a company misses timely Form 10-Qs, 10-Ks, or 8-K disclosures, Nasdaq may consider this a serious compliance failure and start delisting procedures.
• Corporate governance failures: Lack of required independent directors, audit committee composition issues, or failures in internal controls can trigger removal processes.
• Insolvency or bankruptcy: Chapter 11 filings or other insolvency events often lead to suspension and delisting because of uncertainty about the company’s viability.
• Failure to pay Nasdaq fees: Nonpayment of required fees can lead to suspension or delisting.
• Fraud or regulatory enforcement actions: Securities fraud or regulatory sanctions typically result in expedited enforcement and likely delisting.

The precise threshold and applicable rule vary by listing tier and the nature of the deficiency, but these categories capture the main causes that Nasdaq reviews.

Nasdaq’s rules and legal framework

Nasdaq’s delisting process is governed by its Listing Rules (notably the Rule 5800 series and Listing Rule 5810 concerning procedures). The Securities and Exchange Commission (SEC) oversees exchange rulemaking and may review and comment on Nasdaq’s enforcement actions. Key actors in the process include Nasdaq staff (Listing Qualifications), the Nasdaq Hearings Panel, the Listing Council, and, in certain matters, the Nasdaq Board.

• Rule series overview: Listing standards (Rule 5200–5300 series and 5800 series) set quantitative and qualitative requirements; Listing Rule 5810 prescribes the deficiency notice, hearing rights, and appeal mechanisms. Nasdaq’s rulebook explains criteria for continued listing and the procedures to enforce them.
• Enforcement architecture: When Nasdaq identifies noncompliance, Listing Qualifications staff issues notices and manages cure processes. If the issue is unresolved, Nasdaq may issue a decision to delist, which the issuer can contest before the Hearings Panel. Panel decisions can then be appealed to the Listing Council and, in some cases, the SEC or federal courts.

This layered process is designed to balance investor protection with due process for issuers.

Detection and notification: deficiency notices and initial steps

how does a stock get delisted from nasdaq often begins with detection. Nasdaq uses surveillance systems and regular reporting reviews to detect breaches. When a deficiency exists, Nasdaq issues a formal notice (sometimes called a deficiency letter) that identifies the rule(s) implicated and sets a timeline for remediation.

Key points about notification:

• Public disclosure: When a company receives a deficiency notice, it generally must disclose the receipt in an SEC filing (commonly an 8-K) or a public statement, notifying investors that Nasdaq has raised listing concerns.
• Initial remediation plan: The company is expected to present a plan to Nasdaq showing how it intends to regain compliance. That plan forms the basis for Nasdaq’s decision on whether to grant a cure period or other relief.

Notices often start a tightly scheduled procedure. Early and transparent communication with Nasdaq staff improves the likelihood of relief or extensions.

Cure periods and compliance requirements

A central feature of Nasdaq’s process is the cure period — a window during which a company can regain compliance. The length and conditions vary by the type of deficiency and listing tier:

• Minimum bid price tests: Nasdaq commonly measures compliance by requiring a company to maintain a minimum closing bid above $1.00 for a specified number of consecutive trading days (frequently ten consecutive trading days for an initial compliance test under a typical 180-day extension, though exact counts depend on rule amendments and listing tier). If a company receives a bid price deficiency notice, Nasdaq may provide an initial compliance period (often 180 calendar days) to regain the required price.
• Alternative compliance periods: For some deficiencies, Nasdaq offers shorter or longer windows (e.g., 90 days, 180 days), or may provide an extension if the company shows credible remediation steps. Extensions are discretionary and require persuasive documentation.
• Other compliance tests: For market value and shareholder equity deficiencies, Nasdaq may ask a company to meet a quantitative standard by a deadline or otherwise face delisting. For failure-to-file issues, Nasdaq may set a cure window tied to the company’s ability to file required SEC reports and demonstrate governance and disclosure controls.

The cure period mechanics vary; issuers should consult Nasdaq’s current rules and their Listing Qualifications analyst for precise deadlines and conditions.

Measures companies use to regain compliance

When companies face delisting risks, they commonly employ several remedies to regain compliance quickly:

• Reverse stock split: Raising the per-share price through a reverse split is a common fix for minimum bid price deficiencies. A reverse split reduces share count and increases the stock price proportionally, often allowing the company to clear the minimum bid test if market demand remains.
• Capital raises or secondary offerings: Issuing new equity or completing private placements can raise market capitalization or public float levels required for listing.
• Timely SEC filings: Catching up on overdue Form 10-Qs, 10-Ks, or other required disclosures can halt delisting for reporting failures and restore investor confidence.
• Governance remediation: Reconstituting the board, appointing independent directors, forming an audit committee, and fixing internal controls can address governance-based delisting risks.
• Strategic transactions: Mergers, asset sales, or other corporate transactions can change the company’s profile and address listing deficiencies.

Issuers must weigh the costs and shareholder approval requirements (e.g., reverse split votes) and communicate clearly with Nasdaq and investors.

Delisting determination, hearing and appeals process

If a company does not regain compliance within the cure period, Nasdaq may issue a formal delisting determination. The company has procedural rights:

• Requesting a hearing: Generally, companies have a limited window (commonly seven calendar days from receipt of the delisting determination) to request a hearing before a Nasdaq Hearings Panel.
• Hearings Panel role: The Hearings Panel reviews evidence, hears argument, and can decide to grant an exception, continue the listing under conditions, or uphold delisting. Panels evaluate whether the issuer has met a fair and reasonable remediation plan and whether public interest supports continued listing.
• Further appeals: Panel decisions can often be appealed to the Listing Council and, depending on the rules, to the Nasdaq Board. After internal appeals are exhausted, an issuer may seek review by the SEC. Judicial review through federal courts is sometimes available but limited.
• Timing: While appeals proceed, Nasdaq may or may not permit continued listing. In some cases, delisting actions proceed pending appeal; in others, Nasdaq suspends trading pending resolution. Filing an appeal does not automatically guarantee the security remains listed.

Understanding these procedural timelines and preparing a robust hearing record is critical for issuers contesting delisting.

Suspension, final delisting and timing

When Nasdaq determines delisting is appropriate and internal appeals are unsuccessful or not requested, the exchange will notify the public and begin suspension and delisting steps.

• Suspension: Nasdaq may suspend trading in the security before formal delisting, especially where investor protection concerns exist (e.g., fraud or inaccurate financial statements). Suspension halts Nasdaq trading until resolution.
• Final delisting: After suspension and completion of procedures, Nasdaq will remove the security from its market. Nasdaq issues public notices and the company must continue to meet SEC reporting requirements unless it deregisters.
• Timing: The interval from initial deficiency notice to final delisting can range from a few months (for simple bid-price cases with cure windows) to much shorter timelines when fraud or bankruptcy is involved. The process timelines vary significantly by case facts and the issuer’s actions.

Trading and market consequences after delisting

how does a stock get delisted from nasdaq affects liquidity, price discovery, and market access. Typical consequences include:

• Move to OTC markets: After delisting, many securities trade on over-the-counter (OTC) markets (e.g., OTC Pink). Trading venues off Nasdaq generally have lower liquidity and visibility.
• Reduced liquidity and wider spreads: Delisted shares commonly experience steep declines in daily volume, larger bid-ask spreads, and more volatile price swings.
• Institutional investor constraints: Many institutional investors and funds have mandates to hold only exchange-listed securities or to avoid low-liquidity OTC stocks, prompting forced selling and downward pressure on price.
• Loss of transparency: OTC trading can reduce the depth of public information and diminish the quality of price discovery.
• Broker and custody implications: Brokerage platforms may impose restrictions on trading or margin; certain broker algorithms may delist or downgrade an asset from active trading lists.

Investors in delisted securities face higher trading costs and execution risk and should verify the trading venue and liquidity before acting.

Relisting possibilities and constraints

Relisting on Nasdaq is possible but not automatic. To relist, a company must again meet all applicable listing standards and complete any formal application processes. Typical steps and constraints:

• Cure and re-application: The issuer must remedy the deficiencies (e.g., restore minimum bid price, complete financial filings, fix governance) and apply to Nasdaq demonstrating compliance.
• Time and documentation: Nasdaq requires documentation of remediation, audited financials where applicable, and often a waiting period to confirm sustained compliance.
• Rarity and practical hurdles: Relisting is relatively rare because many companies that are delisted face ongoing financial or governance issues that prevent quick remediation. Investor trust and market interest must also be restored.

Companies contemplating relisting should engage early with Nasdaq and prepare a full compliance package.

Impacts on stakeholders

Delisting affects multiple stakeholders differently:

• Investors: Retail and institutional holders may see immediate declines in liquidity and valuation. Tax considerations (realized losses, recordkeeping) and the operational difficulty of trading on OTC venues are important practical effects.
• Institutional holders: Many institutions have policies limiting holdings in non-exchange-listed securities; this can trigger portfolio rebalancing or forced sales.
• Employees and executives: Stock-based compensation and morale can suffer; equity-based incentives such as options or restricted stock may lose value or become harder to realize.
• Creditors and counterparties: Delisting often signals financial stress that can affect covenant compliance and renegotiation of credit terms.

Stakeholders should monitor company disclosures and plan for operational impacts of trading venue changes.

Preventive and corrective governance for issuers

Companies can reduce delisting risk through disciplined governance and planning:

• Robust compliance and reporting: Maintain processes to file SEC reports on time and ensure accounting controls are effective.
• Monitoring trading metrics: Regularly track bid price, market capitalization, and public float thresholds and model scenarios that could lead to deficiency notices.
• Contingency plans: Pre-authorize or prepare proposals (reverse split approvals, planned capital raises) so remediation can occur quickly.
• Proactive Nasdaq engagement: Communicate early with Nasdaq Listing Qualifications staff and use the Listing Qualifications Analyst resource to understand options and request extensions.
• Governance upkeep: Maintain required board compositions, independent committees, and documented internal control processes.

Proactive governance is frequently the most cost-effective path to keep a company in good standing on Nasdaq.

Investor guidance: what to do if you own a delisted stock

If you hold a stock facing or experiencing delisting, consider the following factual steps and checks:

• Confirm why delisting occurred: Review the company’s SEC filings and Nasdaq notices to understand the exact trigger and timeline.
• Check the trading venue and ticker: After delisting, confirm whether the security trades OTC and whether the ticker symbol changes. Your broker or trading platform should provide details.
• Assess liquidity and risk: Expect wider spreads and lower volume. Limit orders and smaller trade sizes may help manage execution risk.
• Consider tax and recordkeeping: Delisting can complicate tax reporting. Retain transaction records and consult a tax professional for implications of realized losses or transfers.
• Seek professional advice: For significant positions, consult a licensed financial or legal advisor. Do not treat this guide as investment advice.
• Use custodial tools: If you need a secure self-custody option for related digital assets or to research trading alternatives, consider Bitget Wallet for Web3 interactions and Bitget exchange for liquid market access in permitted assets.

These steps help investors navigate the operational and financial implications of delisting.

Special cases: bankruptcy, fraud, mergers, and voluntary delisting

Special circumstances influence the delisting pathway:

• Bankruptcy: A Chapter 11 or similar filing typically results in rapid suspension and delisting because the company’s equity value and governance status are highly uncertain.
• Fraud or regulatory enforcement: Evidence of fraud often leads to expedited suspension and removal to protect investors.
• Mergers and acquisitions: In voluntary delistings tied to M&A (where the company is being acquired), shareholders usually approve the transaction and trade ultimately migrates to the acquirer’s security or is cashed out.
• Voluntary going-private actions: Management-led going-private transactions require shareholder approvals and SEC filings; Nasdaq’s role is procedural rather than punitive in such voluntary delistings.

Procedures and timelines differ materially in these special cases — bankruptcy and fraud typically produce the most immediate market actions.

Notable historical examples (illustrative)

Below are brief illustrative examples that show how the mechanics can play out. These are descriptive summaries to demonstrate process, not endorsements.

• Example A (reverse split remediation): A small-cap issuer received a minimum bid price deficiency and performed a reverse split, regained the required closing price for the prescribed consecutive-day test, and exited the deficiency process without a hearing.
• Example B (failure to file): An issuer with delinquent SEC reports received a delisting determination after failing to file multiple 10-Qs; the company requested a hearing, submitted audited financials, and negotiated additional time to meet requirements.
• Example C (bankruptcy-driven delisting): A company that filed for Chapter 11 experienced immediate trading suspension and was ultimately delisted; its shares migrated to OTC trading and remained illiquid as restructuring proceeded.

These examples illustrate typical outcomes; specific facts and responses determine final resolutions.

References and further reading

Recommended primary sources and authoritative references include Nasdaq’s Listing Rules (Rules under the 5800 series and Listing Rule 5810), Nasdaq continued listing guidance, and the SEC’s oversight documents. For practical explanations, legal firm summaries and reputable financial education sites provide helpful overviews. As of 23 January 2026, Nasdaq remains the primary legal source for specific rule text and procedural updates.

Source notes: As of 23 January 2026, according to Nasdaq’s publicly available Listing Rules and guidance, the cure periods and hearing rights summarized above reflect standard practice. Secondary explanations come from published legal summaries and financial education sources that describe how delisting processes function in practice.

Appendix: Typical timelines and procedural checklist

Below is a concise timeline many issuers and investors will encounter:

• Trigger identified (e.g., sustained sub-$1.00 closing bid) → Nasdaq issues deficiency notice.
• Company disclosure and remediation plan submitted → Nasdaq evaluates and typically grants a cure period (commonly 90–180 days depending on the rule).
• Company attempts remediation (reverse split, filings, capital raises) → If compliance is achieved under the required test (e.g., consecutive trading days), Nasdaq closes the matter.
• If not cured → Nasdaq issues a delisting determination and the company has about seven calendar days to request a hearing.
• Hearings Panel review → Panel issues decision; issuer can appeal internally to the Listing Council or file for SEC review.
• If appeals fail or are not timely filed → Nasdaq may suspend trading and delist the security; trading may move to OTC markets.

This checklist is a practical quick reference; always check Nasdaq’s current rulebook for precise deadlines and processes.

Practical takeaways and next steps

how does a stock get delisted from nasdaq is a process that combines bright-line quantitative tests with discretionary, rule-based procedures. For issuers, active monitoring, rapid remediation plans, and early engagement with Nasdaq increase the chance of a positive outcome. For investors, confirming the cause of delisting, understanding the new trading venue, and evaluating liquidity and tax consequences are essential steps.

If you are an issuer preparing for potential delisting, consult your Listing Qualifications analyst at Nasdaq and prepare corporate actions that can be executed quickly. If you are an investor holding a security that moved off Nasdaq, confirm tradeability and custody arrangements with your broker, and consider consulting a licensed advisor for significant holdings.

Explore more resources and trading options on Bitget to manage exposure in regulated, liquid markets, and use Bitget Wallet for secure custody and Web3 interactions.

Actionable resources

• If you are a corporate officer: immediately review Nasdaq’s notice, prepare remediation documentation, and consider board-level authorization for contingency actions (reverse split approvals, capital raises).
• If you are an investor: check your broker’s status updates, confirm the post-delisting trading venue, and document your transactions for tax purposes.

To learn more about markets, custody, and trading alternatives in a regulated environment, explore Bitget’s educational content and Bitget Wallet for secure asset management.

This article is informational and not investment advice. Consult legal and financial professionals when making decisions related to delisting, trading, or corporate actions.